Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Syncytial Virus Respiratory Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01483911
What this trial is testing

ALX-0171 Phase I Study, Evaluating Single Ascending Dose and Multiple Dose in Healthy Male Volunteers

Who this might be right for
RSV Infection
Ablynx, a Sanofi company 60
Testing effectiveness (Phase 2)Ended earlyNCT03418571
What this trial is testing

Evaluation of ALX-0171 in Japanese Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection

Who this might be right for
Respiratory Syncytial Virus Lower Respiratory Tract Infection
Ablynx, a Sanofi company 15
Not applicableLooking for participantsNCT04959734
What this trial is testing

COVID-19 Impact on RSV Emergency Presentations

Who this might be right for
Bronchiolitis; Respiratory Syncytial Virus
University Hospitals, Leicester 3,000
Early research (Phase 1)Study completedNCT00192504
What this trial is testing

Safety Study of a Monoclonal Antibody to Respiratory Syncytial Virus (RSV) in Children Hospitalized With RSV Infection

Who this might be right for
Respiratory Syncytial Virus Prophylaxis
MedImmune LLC 31
Not applicableStudy completedNCT00524693
What this trial is testing

Montelukast in Acute RSV Bronchiolitis

Who this might be right for
Bronchiolitis
Ziv Hospital 51
Not applicableUnknownNCT06318936
What this trial is testing

Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands

Who this might be right for
RSV Infection
UMC Utrecht 100
Large-scale testing (Phase 3)Active Not RecruitingNCT07220109
What this trial is testing

A Study on the Immune Response and Safety of Vaccine Against Respiratory Syncytial Virus Given to Chinese Adults 18 to 59 Years of Age at Increased Risk of Respiratory Syncytial Virus Disease

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 750
Not applicableStudy completedNCT06424795
What this trial is testing

Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants

Who this might be right for
Respiratory Syncytial Virus Infection
University of Rochester 100
Testing effectiveness (Phase 2)Study completedNCT00316264
What this trial is testing

Study of Motavizumab (MEDI-524) and Palivizumab Administered Sequentially in the Same Respiratory Syncytial Virus (RSV) Season

Who this might be right for
Respiratory Syncytial Virus InfectionsChronic Lung Disease and <= 24 Months of Age orPremature With Gestational Age <=35 Weeks and <=6 Months of Age
MedImmune LLC 260
Early research (Phase 1)Ended earlyNCT02593851
What this trial is testing

Assess the Pharmacokinetics, Safety, and Tolerability of Multiple Doses of Orally Administered JNJ-53718678 in Infants Hospitalized With Respiratory Syncytial Virus (RSV) Infection

Who this might be right for
Respiratory Syncytial Virus InfectionsVirus Diseases
Janssen Sciences Ireland UC 45
Testing effectiveness (Phase 2)Study completedNCT04126213
What this trial is testing

Study of Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline's (GSK)Respiratory Syncytial Virus (RSV)Maternal Unadjuvanted Vaccine in Healthy Pregnant Women (Aged 18 to 40 Years) and Their Infants

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 534
Not applicableStudy completedNCT00420966
What this trial is testing

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

Who this might be right for
Lower Respiratory Tract InfectionRespiratory Syncytial Virus Infections
Sunnybrook Health Sciences Centre 25,003
Large-scale testing (Phase 3)Study completedNCT04938830
What this trial is testing

Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)

Who this might be right for
RSV Infection
Merck Sharp & Dohme LLC 1,003
Early research (Phase 1)Study completedNCT01893554
What this trial is testing

Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in Infants and Children

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 88
Not applicableUnknownNCT01437956
What this trial is testing

KL-6 Protein as a Biomarker of Lung Injury in Viral Bronchiolitis

Who this might be right for
Acute Viral Bronchiolitis
University Hospital, Clermont-Ferrand 200
Not applicableStudy completedNCT01545245
What this trial is testing

Effects of Preventive Treatment for Respiratory Syncytial (RS) Virus Infection During Infancy on Later Atopic Asthma in Preterm Infants

Who this might be right for
Atopic AsthmaRecurrent Wheezing
Tokai University 343
Not applicableLooking for participantsNCT07640581
What this trial is testing

Epidemiological Characteristics and Clinical Burden of RSV Infection in Children Under 24 Months in Ho Chi Minh City (2026-2028)

Who this might be right for
Acute Respiratory Infections (ARIs)
Tam Anh Research Institute 2,000
Not applicableStudy completedNCT06336577
What this trial is testing

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Who this might be right for
Down Syndrome
Centre Hospitalier Sud Francilien 108
Not applicableStudy completedNCT06977971
What this trial is testing

RSV Antibiotic Drivers And Resource-use

Who this might be right for
Respiratory Syncytial Virus InfectionsAntibiotic Stewardship in Community Hospitals
Dr. Behcet Uz Children's Hospital 209
Not applicableStudy completedNCT07382219
What this trial is testing

Real-World Effectiveness of Nirsevimab Against RSV-Related and All-Cause Respiratory Tract Infections in Chinese Infants

Who this might be right for
RSV InfectionsLower Respiratory Tract Infections
Han Tongyan 816
Next Page